Menu

Wolfson Institute of Preventive Medicine

Search - ZOO
Search - K2
Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

Publications

We maintain an archive of past and current publications which can be searched by clicking on the links to the left or by using the drop down menus at the top of this page to search by author name, journal name or year of publication.

Alternatively you can use the search bar to look up a key word.

Our most recent publications are listed below.

Attila Lorincz Publications

Authors

Publication Summary

Journal

Years

Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, Brown BJ, Lörincz A, Salmeron J, Lazcano-Ponce E Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.. vol.17, (1) 734.
10.1186/s12885-017-3723-5
BMC Cancer2017
Lorincz AT, Nathan M, Reuter C, Warman R, THAHA MA, Sheaff M, Vasiljevic N, Ahmad A, CUZICK JM, Sasieni P Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions. vol.8, (31) 50510 - 50520.
10.18632/oncotarget.17984
Oncotarget2017
Lorincz AT, Nathan M, Reuter C, Warman R, Thaha MA, Sheaff M, Vasiljevic N, Ahmad A, Cuzick J, Sasieni P Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions.. vol.8, (31) 50510 - 50520.
10.18632/oncotarget.17984
Oncotarget2017
Ahmad AS, Vasiljevi¿ N, Carter P, Berney DM, Møller H, Foster CS, Cuzick J, Lorincz AT A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.. vol.7, (44) 71833 - 71840.
10.18632/oncotarget.12377
Oncotarget2016
Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J, FRIDA Study Group Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.. vol.16, () 461 - 461.
10.1186/s12879-016-1782-x
BMC Infect Dis2016
Mao X, Luo F, Boyd LK, Zhou B, Zhang Y, Stankiewicz E, Marzec J, Vasiljevic N, Yu Y, Feng N, Xu J, Lorincz A, Jiang Y, Chelala C, Ren G, Berney DM, Zhao SC, Lu YJ NKAIN2 functions as a novel tumor suppressor in prostate cancer.. vol., () .
10.18632/oncotarget.11690
Oncotarget2016
Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, Austin J, Cuzick J, Vasiljevi¿ N Validation of a DNA methylation HPV triage classifier in a screening sample.. vol.138, (11) 2745 - 2751.
10.1002/ijc.30008
Int J Cancer2016
Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, Lörincz A, Wheeler CM, Castle PE, Robles C, Lazcano-Ponce E HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico.. vol.58, (2) 211 - 219.
10.21149/spm.v58i2.7790
Salud Publica Mex2016
Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, Schmeler KM, Flores YN, Méndez-Hernández P, Salmerón J, FRIDA Study Group Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.. vol.58, (2) 197 - 210.
10.21149/spm.v58i2.7789
Salud Publica Mex2016
Lorincz AT Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention.. vol.60, (6) 501 - 512.
10.1159/000450595
Acta Cytol2016
Louie K, Ashdown-Barr L, Reuter C, Lorincz A, Sasieni P, Zelin J PREVALENCE AND RISK FACTORS ASSOCIATED WITH ORAL HPV AMONG STI CLINIC ATTENDEES. vol.91, () A93 - A93.
10.1136/sextrans-2015-052126.277
SEXUALLY TRANSMITTED INFECTIONS2015
Louvanto K, Franco EL, Ramanakumar AV, Vasiljevi¿ N, Scibior-Bentkowska D, Koushik A, Cuzick J, Coutlée F, Lorincz AT, Biomarkers of Cervical Cancer Risk Study Team Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.. vol.136, (6) E638 - E645.
10.1002/ijc.29196
Int J Cancer2015
Nathan M, Reuter C, Lim A, THAHA MA, Sasieni P, Sheaf M, Lorinz A Prediction of high-grade anal intraepithelial neoplasia using DNA methylation measurements – preliminary data. vol.1, (12) 76 - 92.
10.1071/SHv12n1abs
2015
Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, Lorincz AT HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.. vol.15, (5) 669 - 675.
10.3233/CBM-150507
Cancer Biomark2015
Lorincz A, Raison C Scratching the surface of tomorrow's diagnostics: the Editor-in-Chief's opinion at the 15th year of Expert Review of Molecular Diagnostics.. vol.15, (1) 5 - 8.
10.1586/14737159.2015.998959
Expert Rev Mol Diagn2015
Brentnall AR, Vasiljevi¿ N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, Cuzick J, Lorincz AT A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.. vol.135, (6) 1425 - 1432.
10.1002/ijc.28790
Int J Cancer2014
Vasiljevi¿ N, Ahmad AS, Thorat MA, Fisher G, Berney DM, Møller H, Foster CS, Cuzick J, Lorincz AT DNA methylation gene-based models indicating independent poor outcome in prostate cancer.. vol.14, () 655.
10.1186/1471-2407-14-655
BMC Cancer2014
Lazcano-Ponce E, Lorincz AT, Torres L, Salmeron J, Cruz A, Rojas R, Hernandez P, Hernandez M Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women. vol.135, (1) 109 - 116.
10.1002/ijc.28639
INTERNATIONAL JOURNAL OF CANCER2014
Lorincz AT Cancer diagnostic classifiers based on quantitative DNA methylation.. vol.14, (3) 293 - 305.
10.1586/14737159.2014.897610
Expert Rev Mol Diagn2014
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljevi¿ N, Chaplin T, Xue L, Xu M, Foster JM, Karnam SS, James SY, Chioni A-M, Gould D, Lorincz AT, Oliver RTD, Chelala C, Thomas GM, Shipley JM Identification of ZDHHC14 as a novel human tumour suppressor gene.. vol.232, (5) 566 - 577.
10.1002/path.4327
J Pathol2014
Vasiljevi¿ N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers.. vol.59, (3) 161 - 166.
10.1016/j.jcv.2013.12.014
J Clin Virol2014
Vasiljevi¿ N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.. vol.132, (3) 709 - 714.
10.1016/j.ygyno.2014.02.001
Gynecol Oncol2014
Vasiljevi¿ N, Ahmad AS, Carter PD, Fisher G, Berney DM, Foster CS, Cuzick J, Lorincz AT DNA methylation of PITX2 predicts poor survival in men with prostate cancer.. vol.8, (9) 1143 - 1150.
10.2217/bmm.14.41
Biomark Med2014
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljevíc N, Chaplin T, Xue L, Xu M, Foster JM, Karnam SS, James SY, Chioni AM, Gould D, Lorincz AT, Oliver RTD, Chelala C, Thomas GM, Shipley JM Erratum:Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014); 232: 566-577)). vol.234, (1) 134.
10.1002/path.4396
Journal of Pathology2014
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Marzec J, Vasiljevic N, Chaplin T, Foster JM, Kamam S, Chioni A-M, Gould D, Lorincz AT, Oliver T, Chelala C, Thomas GM, Mather S, Berney D, Young BD, Lu Y-J Identification of ZDHHC14 as a novel human tumour suppressor: gene. vol.34, () S90 - S90.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE2014
Bosch FX, Broker TR, Forman D, Moscicki A-B, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA Comprehensive control of human papillomavirus infections and related diseases.. vol.31 Suppl 8, () I1 - 31.
10.1016/j.vaccine.2013.07.026
Vaccine2013
Lorincz A, Castanon A, Wey Lim AW, Sasieni P New strategies for human papillomavirus-based cervical screening.. vol.9, (5) 443 - 452.
10.2217/whe.13.48
Womens Health (Lond)2013
Lorincz AT, Brentnall AR, Vasiljevi¿ N, Scibior-Bentkowska D, Castanon A, Fiander A, Powell N, Tristram A, Cuzick J, Sasieni P HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.. vol.133, (3) 637 - 644.
10.1002/ijc.28050
Int J Cancer2013
Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. vol.132, (6) 1412 - 1422.
10.1002/ijc.27750
INTERNATIONAL JOURNAL OF CANCER2013
Vasiljevi¿ N, Ahmad AS, Beesley C, Thorat MA, Fisher G, Berney DM, Møller H, Yu Y, Lu Y-J, Cuzick J, Foster CS, Lorincz AT Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.. vol.16, (1) 35 - 40.
10.1038/pcan.2012.47
Prostate Cancer Prostatic Dis2013
Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer. vol.21, (12) 2125 - 2137.
10.1158/1055-9965.EPI-12-0905
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION2012
Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.. vol.104, (22) 1738 - 1749.
10.1093/jnci/djs425
J Natl Cancer Inst2012
Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, J L M Meijer C, Sankaranarayanan R, J F Snijders P, Szarewski A New technologies and procedures for cervical cancer screening.. vol.30 Suppl 5, () F107 - F116.
10.1016/j.vaccine.2012.05.088
Vaccine2012
Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.. vol.30, (25) 3044 - 3050.
10.1200/JCO.2011.38.8389
J Clin Oncol2012
Lorincz AT, Lazcano-Ponce E Self-collection of vaginal specimens for HPV testing Reply. vol.379, (9826) 1588 - 1589.
10.1016/S0140-6736(12)60675-8
LANCET2012
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Chaplin T, Xue L, Xu M, Foster JM, James S, Chioni AM, Jeetle S, Vasiljevic NA, Marzec J, Gould D, Jones L, Lorincz AT, Oliver RTD, Mather SJ, Shipley JM Identification of ZDHHC14 as a novel tumor suppressor gene commonly downregulated in human cancers. vol.72, () .
10.1158/1538-7445.AM2012-4858
CANCER RESEARCH2012
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, Lorincz A, Burk RD Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.. vol.104, (7) 556 - 565.
10.1093/jnci/djs135
J Natl Cancer Inst2012
Mahmud SM, Sangwa-Lugoma G, Nasr SH, Kayembe PK, Tozin RR, Drouin P, Lorincz A, Ferenczy A, Franco EL Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo. vol.124, (2) 286 - 291.
10.1016/j.ygyno.2011.10.031
GYNECOLOGIC ONCOLOGY2012
Cheol Kim D, Thorat MA, Lee MR, Cho SH, Vasiljevi¿ N, Scibior-Bentkowska D, Wu K, Ahmad AS, Duffy S, Cuzick JM, Lorincz AT Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes.. vol.11, (2-3) 75 - 88.
10.3233/CBM-2012-0266
Cancer Biomark2012
Lazcano-Ponce* E, LORINCZ* AT, Cruz-Valdes A, Salmeron J, Uribe P, Velasco-Mondragón E, Hernandez Nevarez P, Diaz Acosta R, Hernández-Avila M Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled triaL. vol.378, (9806) 1868 - 1873.
10.1016/S0140-6736(11)61522-5
Lancet2011
Lorincz AT The Promise and the Problems of Epigenetics Biomarkers in Cancer.. vol.5, (5) 375 - 379.
10.1517/17530059.2011.590129
Expert Opin Med Diagn2011
Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study. vol.20, (7) 1398 - 1409.
10.1158/1055-9965.EPI-11-0206
CANCER EPIDEM BIOMAR2011
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Wacholder S, Lorincz A, Burk RD Methylation of the HPV16 L1 gene is associated with disease progression in a prospective population-based cohort. vol.71, () .
10.1158/1538-7445.AM2011-1991
CANCER RESEARCH2011
Sangwa-Lugoma G, Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.. vol.38, (4) 308 - 315.
10.1097/OLQ.0b013e3181fc6ec0
Sex Transm Dis2011
Lorincz A HPV Genotype Detection Using Hybrid Capture Sample Preparation Combined with Whole Genome Amplification and Multiplex Detection with Luminex XMAP (vol 12, pg 847, 2010). vol.13, (2) 245 - 245.
10.1016/j.jmoldx.2011.01.003
JOURNAL OF MOLECULAR DIAGNOSTICS2011
Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernandez M, Granados-Garcia V, Perez R, Salmeron J HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. vol.22, (2) 261 - 272.
10.1007/s10552-010-9694-3
CANCER CAUSE CONTROL2011
Vasiljevi¿ N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L, Yu Y, Shaw GL, Beltran L, Lu Y-J, Berney DM, Cuzick J, Lorincz AT Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.. vol.30, (4) 151 - 161.
10.3233/DMA-2011-0790
Dis Markers2011
Duffy SW, Mackay J, Thomas S, Anderson E, Evans DG, Fielder H, Fox R, Gray J, Gui G, Macmillan D, Moss S, Rogers C, Sainsbury R, Sibbering M, Boggis C, Burn J, Cuzick J, Haward B, Howell A, Mansel R Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. vol.11, (12) 1127 - 1134.
10.1016/S1470.2045(10)70263.1
LANCET ONCOL2010
Lowe B, Kobayashi L, Lorincz A, Mallonee R, O'Neil D, Thai H, Nazarenko I HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP.. vol.12, (6) 847 - 853.
10.2353/jmoldx.2010.100045
J Mol Diagn2010
Lazcano-Ponce E, Lorincz AT, Salmeron J, Fernandez I, Cruz A, Hernandez P, Mejia I, Hernandez-Avila M A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. vol.21, (10) 1693 - 1700.
10.1007/s10552-010-9598-2
CANCER CAUSE CONTROL2010
Lace MJ, Isacson C, Anson JR, Lorincz AT, Wilczynski SP, Haugen TH, Turek LP Upstream Regulatory Region Alterations Found in Human Papillomavirus Type 16 (HPV-16) Isolates from Cervical Carcinomas Increase Transcription, ori Function, and HPV Immortalization Capacity in Culture. vol.83, (15) 7457 - 7466.
10.1128/JVI.00285-09
J VIROL2009
Oliver T, Lorinez A, Cuzick J Prostate cancer prevention by short-term anti-androgens: the rationale behind design of pilot studies.. vol.181, () 195 - 205.Recent Results Cancer Res2009
Nazarenko I, Kobayashi L, Giles J, Fishman C, Chen G, Lorincz A A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP.. vol.154, (1-2) 76 - 81.
10.1016/j.jviromet.2008.09.002
J Virol Methods2008
Qiao Y-L, Sellors JW, Eder PS, Bao Y-P, Lim JM, Zhao F-H, Weigl B, Zhang W-H, Peck RB, Li L, Chen F, Pan Q-J, Lorincz AT A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.. vol.9, (10) 929 - 936.
10.1016/S1470-2045(08)70210-9
Lancet Oncol2008
Oliver T, Lorincz A, Cuzick J CHEMO-PREVENTION OF: PROSTATE CANCER: THE RATIONALE BEHIND DESIGN OF PILOT STUDIES. vol.28, (5C) 3428 - 3429.ANTICANCER RES2008
Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganga J, Arlindo FC, Maeda MYS, Lorincz A, Dores GB, Costa S, Syrjanen S Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort. vol.19, (4) 251 - 258.
10.1258/ijsa.2007.007179
INT J STD AIDS2008
Oliver RTD, Lorincz A, Cuzick J Prostate cancer prevention by short-term antiandrogens: A novel strategy. vol.6, (3) 32 - 32.
10.1016/S1359-6349(08)70224-6
EJC SUPPLEMENTS2008
Flores YN, Bishai DM, Shah KV, Lazcano-Ponce E, Lorincz A, Hernindez M, Ferris D, Salmeron J Risk factors for cervical cancer among HPV positive women in Mexico. vol.50, (1) 49 - 58.
10.1590/S0036-36342008000100011
SALUD PUBLICA MEXICO2008
Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Braganca JF, Lima TP, Maeda MYS, Lorincz A, Dores GB, Costa S, Syrjanen S, Syrjanen K Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study. vol.15, (2) 97 - 104.
10.1258/jms.2008.007061
J MED SCREEN2008
Dillner L, Pagliusi S, Bray F, Lorincz A, Kjaer SK, Anttila A, Iversen OE, Dillner J, Lehtinen M, Paavonen J Strengthening prevention programs to eliminate cervical cancer in the Nordic countries. vol.87, (5) 489 - 498.
10.1080/00016340801986771
ACTA OBSTET GYN SCAN2008
Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C, Ramachandran S, Bell L, Baquet CR, Lorincz A Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. vol.17, (3) 615 - 622.
10.1111/j.1525-1438.2006.00835.x
INT J GYNECOL CANCER2007
Castle PE, Sadorra M, Garcia FAR, Cullen AP, Lorincz AT, Mitchell AL, Whitby D, Chuke R, Kornegay JR Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.. vol.16, (4) 840 - 843.
10.1158/1055-9965.EPI-06-0909
Cancer Epidemiol Biomarkers Prev2007
Carpenter K, Gay T, Chen G, Lorincz A, Howell R Genotype identification in HPV positive cervical specimens using a bead-based multiplex array. vol.8, (5) 657 - 657.JOURNAL OF MOLECULAR DIAGNOSTICS2006
Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E, Meijer C, Lorincz A, Iftner T The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. vol.66, (21) 10630 - 10636.
10.1158/0008-5472.CAN-06-1057
CANCER RES2006
Hesselink AT, Bulkmans NWJ, Berkhof J, Lorincz AT, Meijer CJLM, Snijders PJF Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.. vol.44, (10) 3680 - 3685.
10.1128/JCM.02078-05
J Clin Microbiol2006
Sangiva-Lugoma G, Mahmud S, Nasr SH, Liaras J, Kavembe PK, Tozin RR, Drouin P, Lorincz A, Ferenczy A, Franco EL Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. vol.119, (6) 1389 - 1395.
10.1002/ijc.21972
INT J CANCER2006
Canadas MP, Lloveras B, Lorincz A, Ejarque M, Font R, Bosch FX, de Sanjose S Assessment of HPV detection assays for use in cervical cancer screening programs.. vol.48, (5) 373 - 378.
10.1590/s0036-36342006000500003
SALUD PUBLICA MEXICO2006
Lowe B, Nazarenko I, Hammad HS, Kobayashi L, Thai H, Lorincz A Multiplex genotyping assay utilizing a new target-specific, hybrid-capture method.. vol.52, (6) A55 - A55.CLINICAL CHEMISTRY2006
Longatto A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SFM, Hammes L, Sarian LO, Braganca JF, Matos J, Gontijo R, Lima T, Maeda MYS, Tatti S, Syrjanen S, Dores G, Lorincz A, Syrjanen K Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study. vol.16, (3) 955 - 962.
10.1111/j.1525-1438.2006.00582.x
INT J GYNECOL CANCER2006
Taha NSA, Focchi J, Ribalta JCL, Castelo A, Lorincz A, Dores GB Universal Collection Medium (UCM)(R) is as suitable as the Standard Transport Medium (STM)(R) for Hybrid Capture II (R) (HC-2) assay. vol.36, (1) 32 - 35.
10.1016/j.jcv.2005.12.011
J CLIN VIROL2006
Alves VAF, Castelo A, Filho AL, Vianna MR, Taromaru E, Namiyama G, Lorincz A, Dores GBD, DNA-Citoliq Working Grp Performance of the DNA-Citoliq liquid-based cytology system compared with conventional smears. vol.17, (2) 86 - 93.
10.1111/j.1365-2303.2006.00279.x
CYTOPATHOLOGY2006
Tu JJ, Kuhn L, Denny L, Beattie KJ, Lorincz A, Wright TC Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa. vol.16, (2) 736 - 742.
10.1111/j.1525-1438.2006.00401.x
INT J GYNECOL CANCER2006
Smulevitch S, Gay T, Khanna R, Chen G, Davis M, Mbwana M, Nazarenko I, Lorincz A, Howell R Identification of 19 human papillomavirus types using a rapid multiplex detection assay format.. vol.7, (5) 671 - 671.JOURNAL OF MOLECULAR DIAGNOSTICS2005
Hernandez-Giron C, Smith JS, Lorincz A, Chaidez EA, Lazcano E, Hernandez-Avila M, Salmeron J The prevalence of high-risk HPV infection in pregnant women from Morelos, Mexico. vol.47, (6) 423 - 429.
10.1590/s0036-36342005000600006
SALUD PUBLICA MEXICO2005
Hernandez-Giron C, Smith JS, Lorincz A, Lazcano E, Hernandez-Avila M, Salmeron J High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. vol.32, (10) 613 - 618.
10.1097/01.olq.0000179888.47309.db
SEX TRANSM DIS2005
Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MYS, Lorincz A, Dores GB, Costa S, Syrjanen S Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. vol.25, (5) 3469 - 3480.ANTICANCER RES2005
Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.. vol.97, (14) 1072 - 1079.
10.1093/jnci/dji187
J Natl Cancer Inst2005
Castle PE, Schiffman M, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Wacholder S, Lorincz AT Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.. vol.14, (5) 1311 - 1314.
10.1158/1055-9965.EPI-04-0799
Cancer Epidemiol Biomarkers Prev2005
Castle PE, Garcia-Meijide M, Holladay EB, Chuke R, Payne J, Long A, Siefers H, Demuth F, Lorincz AT A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II.. vol.123, (2) 250 - 255.
10.1309/MEPB1TAMAD6Q13G3
Am J Clin Pathol2005
Nicolau SM, Camargo CGC, Stavale JN, Castelo A, Dores GB, Lorincz A, De Lima GR Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. vol.65, (2) 251 - 255.
10.1016/j.urology.2004.09.031
UROLOGY2005
Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Braganca JF, Lima TP, Maeda MYS, Lorincz A, Dores GB, Costa S, Syrjanen S, Syrjanen K Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. vol.12, (3) 142 - 149.
10.1258/0969141054855328
J MED SCREEN2005
de Castro Ferraz MDG, Nicolau SM, Stavale JN, Focchi J, Castelo A, Dores GB, Mielzynska-Lohnas I, Lorincz A, de Lima GR Cervical biopsy-based comparison of a new liquid-based thin-layer preparation with conventional Pap smears. vol.30, (4) 220 - 226.
10.1002/dc.10409
DIAGN CYTOPATHOL2004
Obiso R, Lorincz A Digene Corporation.. vol.5, (1) 129 - 132.
10.1517/phgs.5.1.129.25678
Pharmacogenomics2004
Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Howard M, Roth P, Lorincz AT, Gafni A, Walter SD Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.. vol.127, (9) 1169 - 1175.
10.1043/1543-2165(2003)127<1169:AHPTIT>2.0.CO;2
Arch Pathol Lab Med2003
Castle PE, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Wacholder S, Burk RD, Manos MM, Schussler JE, Macomber P, Schiffman M Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.. vol.41, (9) 4022 - 4030.
10.1128/JCM.41.9.4022-4030.2003
J Clin Microbiol2003
Salmeron J, LAzcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. vol.14, (6) 505 - 512.
10.1023/A:1024806707399
CANCER CAUSE CONTROL2003
Lörincz AT, Richart RM Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.. vol.127, (8) 959 - 968.
10.1043/1543-2165(2003)127<959:HPDTAA>2.0.CO;2
Arch Pathol Lab Med2003
Jeronimo J, Castle PE, Herrero R, Sherman ME, Bratti MC, Hildesheim A, Alfaro M, Morales J, Hutchinson ML, Burk RD, Lorincz A, Wacholder S, Rodríguez AC, Schiffman M Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3.. vol.7, (3) 175 - 183.
10.1097/00128360-200307000-00004
J Low Genit Tract Dis2003
Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. vol.12, (6) 477 - 484.CANCER EPIDEM BIOMAR2003
Solomon D, Schiffman M, Tarone R, Partridge EE, Kilgore L, Hester S, Walker JL, Johnson GA, Yadack A, Guido RS, McIntyre-Seltman K, Edwards RP, Gruss J, Kiviat NB, Koutsky L, Mao C, Haug JM, Ferris D, Cox JT, Burke L A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. vol.188, (6) 1393 - 1400.
10.1067/mob.2003.462
AM J OBSTET GYNECOL2003
Lytwyn A, Kaczorowski J, Lorincz A, Sellors JW Transmission of HPV - Reply. vol.168, (11) 1391 - 1391.CAN MED ASSOC J2003
Nonnenmacher B, Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer.. vol.14, (4) 258 - 265.
10.1258/095646203321264872
Int J STD AIDS2003
Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A, SHOW Grp Incidence, clearance and predictors of human papillomavirus infection in women. vol.168, (4) 421 - 425.CAN MED ASSOC J2003
Cullen A, Modarress K, Shults S, Collier C, Lorincz A A simple procedural modification for the hybrid capture 2 HPV DNA test that strengthens accuracy. vol., () 259 - 262.EUROGIN 2003: 5TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS2003
Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.. vol.95, (1) 46 - 52.
10.1093/jnci/95.1.46
J Natl Cancer Inst2003
Flores Y, Bishai D, Lazcano E, Shah K, Lorincz A, Hernandez M, Salmeron J, Morelos HPV Study Collaborators Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study. vol.45, () S388 - S398.SALUD PUBLICA MEXICO2003
Lörincz AT Screening for cervical cancer: new alternatives and research.. vol.45 Suppl 3, () S376 - S387.Salud Publica Mex2003
Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.. vol.95, (10) 2145 - 2151.
10.1002/cncr.10927
Cancer2002
Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A, Schussler JE, Burk RD Comparisons of HPV DNA detection by MY09/11 PCR methods. vol.68, (3) 417 - 423.
10.1002/jmv.10220
J MED VIROL2002
Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. vol.11, (11) 1394 - 1399.CANCER EPIDEM BIOMAR2002
Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.. vol.94, (18) 1406 - 1414.
10.1093/jnci/94.18.1406
J Natl Cancer Inst2002
Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M Viral load of human papillomavirus and risk of CIN3 or cervical cancer.. vol.360, (9328) 228 - 229.
10.1016/S0140-6736(02)09463-1
Lancet2002
Flores Y, Shah K, Lazcano E, Hernandez M, Bishai D, Ferris DG, Lorincz A, Hernandez P, Salmeron J, Morelos HPV Study Collaborators Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study. vol.44, (4) 335 - 344.SALUD PUBLICA MEXICO2002
Pretorius RG, Peterson P, Novak S, Azizi F, Sadeghi M, Lorincz AT Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy.. vol.47, (4) 290 - 296.J Reprod Med2002
Dzuba IG, Diaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV, Bishai D, Lorincz A, Ferris D, Turnbull B, Avila MH, Salmeron J The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. vol.11, (3) 265 - 274.
10.1089/152460902753668466
J WOMEN HEALTH GEN-B2002
Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, Schussler JE, Schiffman M Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.. vol.40, (3) 1088 - 1090.
10.1128/JCM.40.3.1088-1090.2002
J Clin Microbiol2002
Darwin LH, Cullen AP, Arthur PM, Long CD, Smith KR, Girdner JL, Hook EW, Quinn TC, Lorincz AT Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.. vol.40, (2) 641 - 644.
10.1128/JCM.40.02.641-644.2002
J Clin Microbiol2002
Lorincz A Premature diagnosis. vol.169, (2) 16 - +.FORBES2002
Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, Sherman ME, Alfaro M, Hutchinson ML, Morales J, Lorincz A, Burk RD, Carrington M, Erlich HA, Apple RJ Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. vol.184, (10) 1310 - 1314.
10.1086/324209
JOURNAL OF INFECTIOUS DISEASES2001
Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D Shanxi province cervical cancer screening study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. vol.83, (2) 439 - 444.
10.1006/gyno.2001.6370
GYNECOL ONCOL2001
Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A Detection of high-risk HPV types by the Hybrid Capture 2 test. vol.65, (1) 155 - 162.
10.1002/jmv.2015.abs
J MED VIROL2001
Castle PE, Zemlo TR, Burk RD, Scott DR, Sherman ME, Lorincz AT, Kurman RJ, Glass AG, Rush BB, Liaw KL, Schiffman M Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women.. vol.5, (3) 138 - 143.
10.1097/00128360-200107000-00004
J Low Genit Tract Dis2001
Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.. vol.84, (9) 1219 - 1226.
10.1054/bjoc.2001.1779
Br J Cancer2001
Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A, HPV Effectiveness Lowgrade Paps St Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. vol.163, (6) 701 - 707.CAN MED ASSOC J2000
Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. vol.163, (5) 513 - 518.CAN MED ASSOC J2000
Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL, Survey HPV Ontario Women SHOW Grp Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. vol.163, (5) 503 - 508.CAN MED ASSOC J2000
Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. vol.92, (10) 818 - 825.
10.1093/jnci/92.10.818
J NATL CANCER I2000
Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT HPV DNA testing in cervical cancer screening - Results from women in a high-risk province of Costa Rica. vol.283, (1) 87 - 93.
10.1001/jama.283.1.87
JAMA-J AM MED ASSOC2000
Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. vol.283, (1) 81 - 86.
10.1001/jama.283.1.81
JAMA-J AM MED ASSOC2000
Schachter J, Hook EW, McCormack WM, Quinn TC, Chernesky M, Chong S, Girdner JI, Dixon PB, DeMeo L, Williams E, Cullen A, Lorincz A Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. vol.37, (11) 3668 - 3671.J CLIN MICROBIOL1999
Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P HPV testing in primary screening of older women.. vol.81, (3) 554 - 558.
10.1038/sj.bjc.6690730
Br J Cancer1999
Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, Li CJ, Lorincz A, Meehan MP, Wabwire-Mangen F, Gray RH Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. vol.180, (4) 1316 - 1319.
10.1086/315026
JOURNAL OF INFECTIOUS DISEASES1999
Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, Elson P, Fischer C, Lorincz A, Zahniser D, Wilbur D, Pan Q, Li L, Biscotti C, Dawson A, Li A, Wu L, Ling Y, Ma CP, Yang XP Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study.. vol.9, (5) 411 - 417.
10.1046/j.1525-1438.1999.99055.x
Int J Gynecol Cancer1999
Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT Collection devices for human papillomavirus. vol.48, (7) 531 - 535.J FAM PRACTICE1999
Modarress KJ, Cullen AP, Jaffurs WJ, Troutman GL, Mousavi N, Hubbard RA, Henderson S, Lörincz AT Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in swab specimens by the Hybrid Capture II and PACE 2 nucleic acid probe tests.. vol.26, (5) 303 - 308.
10.1097/00007435-199905000-00012
Sex Transm Dis1999
Girdner JL, Cullen AP, Salama TG, He L, Lorincz A, Quinn TC Evaluation of the digene hybrid capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens. vol.37, (5) 1579 - 1581.J CLIN MICROBIOL1999
Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MG, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M Utility of liquid-based cytology for cervical carcinoma screening - Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. vol.87, (2) 48 - 55.
10.1002/(SICI)1097-0142(19990425)87:2<48::AID-CNCR2>3.0.CO;2-D
CANCER CYTOPATHOLOGY1999
Greenberg MD, Reid R, Schiffman M, Campion MJ, Precop SL, Berman NR, Zemlo T, Husain M, Herman G, Omato KH, Lorincz AT A prospective study of biopsy-confirmed cervical intraepithelial neoplasia grade 1: colposcopic, cytological, and virological risk factors for progression.. vol.3, (2) 104 - 110.
10.1046/j.1526-0976.1999.08094.x
J Low Genit Tract Dis1999
Schneider DL, Herrero R, Bratti C, Greenberg MD, Hildesheim A, Sherman ME, Morales J, Hutchinson ML, Sedlacek TV, Lorincz A, Mango L, Wacholder S, Alfaro M, Schiffman M Cervicography screening for cervical cancer among 8460 women in a high-risk population. vol.180, (2) 290 - 298.
10.1016/S0002-9378(99)70202-4
AM J OBSTET GYNECOL1999
Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies (vol 36, pg 3248, 1998). vol.37, (2) 478 - 478.J CLIN MICROBIOL1999
Cox JT, Herbst AL, Kinney W, Lorincz AT, Richart RM, Schiffman MH Advanced Technologies in Cervical Cancer Screening ASCCP Biennial Meeting 1998.. vol.3, (1 Suppl) S8.J Low Genit Tract Dis1999
Lazar JG, Cullen AP, Mielzynska I, Meijide MG, Lorincz AT Hybrid Capture (R): A sensitive signal amplification-based chemiluminescent test for the detection and quantitation of human viral and bacterial pathogens. vol.22, (2) 139 - 151.J CLIN LIGAND ASSAY1999
Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. vol.36, (11) 3248 - 3254.J CLIN MICROBIOL1998
Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States. vol.7, (11) 1035 - 1041.CANCER EPIDEM BIOMAR1998
Sherman ME, Schiffman M, Herrero R, Kelly D, Bratti C, Mango LJ, Alfaro M, Hutchinson ML, Mena F, Hildesheim A, Morales J, Greenberg MD, Balmaceda I, Lorincz AT Performance of a semiautomated Papanicolaou smear screening system - Results of a population-based study conducted in Guanacaste, Costa Rica. vol.84, (5) 273 - 280.
10.1002/(sici)1097-0142(19981025)84:5<273::aid-cncr2>3.3.co;2-r
CANCER CYTOPATHOLOGY1998
Garcia-Meijide M, Eddington N, Brill J, Niesters HGM, Kraiden FE, Cork M, De Medina M, Eddington N, Brill J, Niesters HGM, Fries E, Kraiden M, Cork M, De Medina M, Hill M, Lorincz AT Multi-center evaluation, of the second-generation digene hybrid capture (R) II HBV test. vol.28, (4) 579A - 579A.HEPATOLOGY1998
Garcia-Meijide M, Brill J, Eddington N, Zhu J, Makar A, Lorincz AT Performance characteristics of the digene hybrid Capture (R) II hepatitis B DNA test. vol.28, (4) 486A - 486A.HEPATOLOGY1998
He L, Arthur P, Long C, Smith K, Cullen A, Hook EW, Lorincz A Evaluation of the digene hybrid Capture (R) II CT/GC test for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in a clinical population. vol.7, (5) 625 - 625.J WOMENS HEALTH1998
Lorincz A Hybrid capture. vol.44, (6) 1363 - 1363.CLIN CHEM1998
Nindl I, Lorincz A, Mielzynska I, Petry U, Baur S, Kirchmayr R, Michels W, Schneider A Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. vol.10, (1) 49 - 56.
10.1016/S0928-0197(98)00015-4
CLIN DIAGN VIROL1998
Wright TC, Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, Borgatta L Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. vol.178, (5) 962 - 966.
10.1016/S0002-9378(98)70531-9
AM J OBSTET GYNECOL1998
Lorincz A, Cullen A, Long C Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test - Authors' reply. vol.36, (3) 852 - 852.J CLIN MICROBIOL1998
Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Woodward L Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCIS and LSIL. vol.46, (2) 136 - 141.J FAM PRACTICE1998
Ferris DG, Wright TC, Litaker S, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R Triage of women with ASCUS and LSIL on Pap smear reports: Management by repeat Pap smear, HPV DNA testing, or colposcopy?. vol.46, (2) 125 - 134.J FAM PRACTICE1998
Chesebro MJ, Everett DW, Lörincz A High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions.. vol.1, (4) 234 - 239.
10.1097/00128360-199710000-00007
J Low Genit Tract Dis1997
Garcia M, Chan WM, DeMedina M, OSullivan H, Schiff ER, Lorincz AT Hybrid capture II(R), a new quantitative test for hepatitis B DNA.. vol.26, (4) 750 - 750.HEPATOLOGY1997
Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR Immune activation in cervical neoplasia: Cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. vol.6, (10) 807 - 813.CANCER EPIDEM BIOMAR1997
Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, Burk RD, Glass AG, Greer C, Buckland J, Helgesen K, Scott DR, Sherman ME, Kurman RJ, Liaw KL Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. vol.35, (9) 2262 - 2265.J CLIN MICROBIOL1997
Cullen AP, Long CD, Lörincz AT Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test.. vol.35, (9) 2275 - 2278.J Clin Microbiol1997
Arthur PM, Cullen A, He L, Smith K, Hook E, Lorincz A Comparison of hybrid capture(TM) microplate DNA detection of Chlamydia trachomatis and Neisseria gonorrhoeae to conventional culture methods in a clinical population.. vol.43, () 780 - 780.CLIN CHEM1997
Sherman ME, Schiffman MH, Mango LJ, Kelly D, Acosta D, Cason Z, Elgert P, Zaleski S, Scott DR, Kurman RJ, Stoler M, Lorincz AT Evaluation of PAPNET testing as an ancillary tool to clarify the status of the ''atypical'' cervical smear. vol.10, (6) 564 - 571.MODERN PATHOL1997
Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. vol.81, (2) 89 - 97.
10.1002/(SICI)1097-0142(19970425)81:2<89::AID-CNCR2>3.3.CO;2-B
CANCER CYTOPATHOLOGY1997
Tabbara SO, Sherman ME, Schiffman MH, Glass AG, Cadell DM, Rush BB, Scott DR, Kurman RJ, Lorincz A, Manos MM ASCUS vs HSIL: Evaluation of the morphologic features.. vol.76, (1) 212 - 212.LAB INVEST1997
Lorincz AT Methods of DNA hybridization and their clinical applicability to human papillomavirus detection. vol., () 325 - 337.NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION1997
Lorincz AT, Reid R Human papillomavirus II - Preface. vol.23, (4) R11 - R12.
10.1016/S0889-8545(05)70274-6
OBSTET GYN CLIN N AM1996
Lörincz AT Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.. vol.22, (6) 629 - 636.
10.1111/j.1447-0756.1996.tb01081.x
J Obstet Gynaecol Res1996
Wideroff L, Schiffman MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Buckland J, Lowy D, Schiller J Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women. vol.174, (5) 937 - 943.
10.1093/infdis/174.5.937
J INFECT DIS1996
Lorincz AT, Reid R Human papillomavirus .1. Preface. vol.23, (3) R9 - R10.OBSTET GYN CLIN N AM1996
Hall S, Lorincz A, Shah F, Sherman ME, Abbas F, Paull G, Kurman RJ, Shah KV Human papillomavirus DNA detection in cervical specimens by hybrid capture: Correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. vol.62, (3) 353 - 359.
10.1006/gyno.1996.0248
GYNECOL ONCOL1996
Tsukui T, Hildesheim A, Schiffman MH, Lucci J, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu WM, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology. vol.56, (17) 3967 - 3974.CANCER RES1996
Lörincz AT Molecular methods for the detection of human papillomavirus infection.. vol.23, (3) 707 - 730.Obstet Gynecol Clin North Am1996
WIDEROFF L, SCHIFFMAN MH, NONNENMACHER B, HUBBERT N, KIRNBAUER R, GREER CE, LOWY D, LORINCZ AT, MANOS MM, GLASS AG, SCOTT DR, SHERMAN ME, KURMAN RJ, BUCKLAND J, TARONE RE, SCHILLER J EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA. vol.172, (6) 1425 - 1430.
10.1093/infdis/172.6.1425
J INFECT DIS1995
LAZAR J, SALIM H, SCEARCE L, LORINCZ A IMPROVED DETECTION OF CMV VIREMIA - A MULTICENTER TRIAL OF THE HYBRID CAPTURE(TM) CMV DNA ASSAY. vol.41, (11) 3 - 3.CLIN CHEM1995
SCHIFFMAN MH, KIVIAT NB, BURK RD, SHAH KV, DANIEL RW, LEWIS R, KUYPERS J, MANOS MM, SCOTT DR, SHERMAN ME, KURMAN RJ, STOLER MH, GLASS AG, RUSH BB, MIELZYNSKA I, LORINCZ AT ACCURACY AND INTERLABORATORY RELIABILITY OF HUMAN PAPILLOMAVIRUS DNA TESTING BY HYBRID CAPTURE. vol.33, (3) 545 - 550.J CLIN MICROBIOL1995
COX JT, LORINCZ AT, SCHIFFMAN MH, SHERMAN ME, CULLEN A, KURMAN RJ HUMAN PAPILLOMAVIRUS TESTING BY HYBRID CAPTURE APPEARS TO BE USEFUL IN TRIAGING WOMEN WITH A CYTOLOGIC DIAGNOSIS OF ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE. vol.172, (3) 946 - 954.
10.1016/0002-9378(95)90026-8
AM J OBSTET GYNECOL1995
REID R, LORINCZ AT HUMAN PAPILLOMAVIRUS TESTS. vol.9, (1) 65 - 103.
10.1016/S0950-3552(05)80359-1
BAILLIERE CLIN OB GY1995
LORINCZ A Hybrid capture(TM): A simple, sensitive method for the routine detection of HPV DNA. vol., () 59 - 62.SCREENING OF CERVICAL CANCER FOR WHOM, WHY AND HOW?, EXPERTS' CONFERENCE1995
SHERMAN ME, SCHIFFMAN MH, LORINCZ AT, MANOS MM, SCOTT DR, KURMAN RJ, KIVIAT NB, STOLER M, GLASS AG, RUSH BB TOWARD OBJECTIVE QUALITY ASSURANCE IN CERVICAL CYTOPATHOLOGY - CORRELATION OF CYTOPATHOLOGIC DIAGNOSES WITH DETECTION OF HIGH-RISK HUMAN PAPILLOMAVIRUS TYPES. vol.102, (2) 182 - 187.
10.1093/ajcp/102.2.182
AM J CLIN PATHOL1994
ISACSON C, LORINCZ A, ZALESKI S, STEINER A, BOTTLES K HUMAN PAPILLOMAVIRUS DNA DETECTION AND GLANDULAR ATYPIA IN CERVICAL SMEARS. vol.70, (1) A38 - A38.LAB INVEST1994
KESSIS TD, SLEBOS RJ, NELSON WG, KASTAN MB, PLUNKETT BS, HAN SM, LORINCZ AT, HEDRICK L, CHO KR HUMAN PAPILLOMAVIRUS-16 E6 EXPRESSION DISRUPTS THE P53-MEDIATED CELLULAR-RESPONSE TO DNA DAMAGE. vol.90, (9) 3988 - 3992.
10.1073/pnas.90.9.3988
P NATL ACAD SCI USA1993
CHAPMAN WB, LORINCZ AT, WILLETT GD, WRIGHT VC, KURMAN RJ METHODS IN PATHOLOGY - EVALUATION OF 2 COMMERCIALLY AVAILABLE INSITU HYBRIDIZATION KITS FOR DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN CERVICAL BIOPSIES - COMPARISON TO SOUTHERN BLOT HYBRIDIZATION. vol.6, (1) 73 - 79.MODERN PATHOL1993
ISACSON C, HAUGEN TH, WILCZYNSKI S, LORINCZ A, TUREK LP STRUCTURE OF INTEGRATED HUMAN PAPILLOMAVIRUS GENOMES IN CERVICAL CARCINOMAS. vol.68, (1) A74 - A74.LAB INVEST1993
Goldsborough MD, McAllister P, Reid R, Temple G, Lorincz AT A comparison study of human papillomavirus prevalence by the polymerase chain reaction in low risk women and in a gynaecology referral group at elevated risk for cervical cancer.. vol.6, (6) 451 - 457.
10.1016/0890-8508(92)90041-U
Mol Cell Probes1992
MUNOZ N, BOSCH FX, DESANJOSE S, TAFUR L, IZARZUGAZA I, GILI M, VILADIU P, NAVARRO C, MARTOS C, ASCUNCE N, GONZALEZ LC, KALDOR JM, GUERRERO E, LORINCZ A, SANTAMARIA M, DERUIZ PA, ARISTIZABAL N, SHAH K THE CAUSAL LINK BETWEEN HUMAN PAPILLOMAVIRUS AND INVASIVE CERVICAL-CANCER - A POPULATION-BASED CASE-CONTROL STUDY IN COLOMBIA AND SPAIN. vol.52, (5) 743 - 749.
10.1002/ijc.2910520513
INT J CANCER1992
CHAPMAN WB, LORINCZ AT, WILLETT GD, WRIGHT VC, KURMAN RJ EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AND THE PRESENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS. vol.11, (3) 221 - 226.
10.1097/00004347-199207000-00009
INT J GYNECOL PATHOL1992
KIVIAT NB, KOUTSKY LA, CRITCHLOW CW, LORINCZ AT, CULLEN AP, BROCKWAY J, HOLMES KK PREVALENCE AND CYTOLOGIC MANIFESTATIONS OF HUMAN PAPILLOMA-VIRUS (HPV) TYPE-6, TYPE-11, TYPE-16, TYPE-18, TYPE-31, TYPE-33, TYPE-35, TYPE-42, TYPE-43, TYPE-44, TYPE-45, TYPE-51, TYPE-52, AND TYPE-56 AMONG 500 CONSECUTIVE WOMEN. vol.11, (3) 197 - 203.
10.1097/00004347-199207000-00005
INT J GYNECOL PATHOL1992
Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.. vol.79, (3) 328 - 337.
10.1097/00006250-199203000-00002
Obstet Gynecol1992
Lörincz A Detection of human papillomavirus DNA without amplification: prospects for clinical utility.. vol., (119) 135 - 145.IARC Sci Publ1992
CHAPMAN W, LORINCZ A, WILLETT G, WRIGHT C, KURMAN R SENSITIVITY OF THE OMNIPROBE KIT AS COMPARED TO SOUTHERN BLOT FOR THE DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN CERVICAL BIOPSIES. vol.66, (1) A62 - A62.LAB INVEST1992
Nasseri M, Gage JR, Lorincz A, Wettstein FO Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7.. vol.184, (1) 131 - 140.
10.1016/0042-6822(91)90829-Z
Virology1991
LORINCZ A THE DETECTION OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION USING POLYMERASE CHAIN-REACTION. vol.265, (21) 2809 - 2809.
10.1001/jama.265.21.2809b
JAMA-J AM MED ASSOC1991
REID R, GREENBERG MD, LORINCZ A, JENSON AB, LAVERTY CR, HUSAIN M, DAOUD Y, ZADO B, WHITE T, CANTOR D, GOLDRATH M SHOULD CERVICAL CYTOLOGIC TESTING BE AUGMENTED BY CERVICOGRAPHY OR HUMAN PAPILLOMAVIRUS DEOXYRIBONUCLEIC-ACID DETECTION. vol.164, (6) 1461 - 1471.
10.1016/0002-9378(91)91425-V
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY1991
SCHIFFMAN MH, BAUER HM, LORINCZ AT, MANOS MM, BYRNE JC, GLASS AG, CADELL DM, HOWLEY PM COMPARISON OF SOUTHERN BLOT HYBRIDIZATION AND POLYMERASE CHAIN-REACTION METHODS FOR THE DETECTION OF HUMAN PAPILLOMAVIRUS DNA. vol.29, (3) 573 - 577.J CLIN MICROBIOL1991
Cullen AP, Reid R, Campion M, Lörincz AT Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.. vol.65, (2) 606 - 612.J Virol1991
Lörincz A Detection of sexually transmitted pathogens with nucleic acid techniques.. vol.50, () 39 - 41.Ups J Med Sci Suppl1991
Lorincz AT, Schiffman MH, Jaffurs WJ, Marlow J, Quinn AP, Temple GF Temporal associations of human papillomavirus infection with cervical cytologic abnormalities.. vol.162, (3) 645 - 651.
10.1016/0002-9378(90)90974-C
Am J Obstet Gynecol1990
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, LORINCZ AT, Burk RD Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population. vol.104, (7) 556 - 565.
10.1093/jnci/djs135
Journal of the National Cancer Institute
Vasiljevic N, Carter P, Reuter C, Warman R, Brentnall A, Carton J, CUZICK JM, Lorincz A Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia. vol., () .
10.1002/ijc.30783
International Journal of Cancer
Return to top